Ecotoxicology and Wildlife Health Division, Wildlife and Landscape Science Directorate, Science and Technology Branch, National Wildlife Research Centre, Environment Canada, Carleton University, Ottawa, ON K1A 0H3, Canada.
Chemosphere. 2013 Sep;93(3):574-80. doi: 10.1016/j.chemosphere.2013.07.013. Epub 2013 Aug 3.
Perfluorooctane sulfonate (PFOS) is a globally distributed persistent organic pollutant that has been found to bioaccumulate and biomagnify in aquatic food webs. Although principally in its linear isomeric configuration, 21-35% of the PFOS manufactured via electrochemical fluorination is produced as a branched structural isomer. PFOS isomer patterns were investigated in multiple tissues of polar bears (Ursus maritimus) from East Greenland. The liver (n = 9), blood (n = 19), brain (n = 16), muscle (n = 5), and adipose (n = 5) were analyzed for linear PFOS (n-PFOS), as well as multiple mono- and di-trifluoromethyl-substituted branched isomers. n-PFOS accounted for 93.0 ± 0.5% of Σ-PFOS isomer concentrations in the liver, whereas the proportion was significantly lower (p<0.05) in the blood (85.4 ± 0.5%). Branched isomers were quantifiable in the liver and blood, but not in the brain, muscle, or adipose. In both the liver and blood, 6-perfluoromethylheptane sulfonate (P6MHpS) was the dominant branched isomer (2.61 ± 0.10%, and 3.26 ± 0.13% of Σ-PFOS concentrations, respectively). No di-trifluoromethyl-substituted isomers were detectable in any of the tissues analyzed. These tissue-specific isomer patterns suggest isomer-specific pharmacokinetics, perhaps due to differences in protein affinities, and thus differences in protein interactions, as well transport, absorption, and/or metabolism in the body.
全氟辛烷磺酸 (PFOS) 是一种在全球范围内分布的持久性有机污染物,已被发现在水生食物网中生物积累和生物放大。尽管主要以线性异构体构型存在,但通过电化学氟化制造的 PFOS 中有 21-35% 是以支化结构异构体的形式产生的。在东格陵兰的北极熊 (Ursus maritimus) 的多个组织中研究了 PFOS 异构体模式。对 9 只肝脏 (n = 9)、19 只血液 (n = 19)、16 只大脑 (n = 16)、5 只肌肉 (n = 5) 和 5 只脂肪 (n = 5) 中的线性 PFOS (n-PFOS) 以及多种单-和二-三氟甲基取代的支化异构体进行了分析。n-PFOS 占肝脏中 Σ-PFOS 异构体浓度的 93.0 ± 0.5%,而在血液中的比例明显较低 (p<0.05) (85.4 ± 0.5%)。支化异构体在肝脏和血液中是可量化的,但在大脑、肌肉或脂肪中则不可量化。在肝脏和血液中,6-全氟甲基庚烷磺酸 (P6MHpS) 是主要的支化异构体 (分别占 Σ-PFOS 浓度的 2.61 ± 0.10%和 3.26 ± 0.13%)。在所分析的组织中均未检测到二-三氟甲基取代的异构体。这些组织特异性的异构体模式表明存在异构体特异性的药代动力学,这可能是由于蛋白质亲和力的差异,从而导致蛋白质相互作用、以及体内的运输、吸收和/或代谢的差异所致。